Inventor profile of:

Alessandro SETTE

City:

La Jolla, California

Country:

United States

Published Applications:

75

Last publication date:

2026-04-30

Top Assignees for applications by Alessandro SETTE

The entities that hold a legal rights for patent applications filed by inventor SETTE Alessandro:

Recent patent applications by SETTE Alessandro

Alessandro SETTE from La Jolla, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-30
US20260115269A1
Human necessities

MYCOBACTERIUM T CELL EPITOPES, MEGAPOOLS AND USES THEREOF

#2 | 2026-02-12
US20260041755A1
Human necessities

ALPHAVIRUS T CELL EPITOPES, MEGAPOOLS AND USES THEREOF

#3 | 2026-01-01
US20260000710A1
Human necessities

Novel Treatments for Cardiovascular Related Disease

#4 | 2025-11-06
US20250341513A1
Physics

Bordetella T Cells Epitopes, Megapools and Uses Thereof

#5 | 2025-10-30
US20250332249A1
Human necessities

CYTOMEGALOVIRUS T CELL EPITOPES AND USES THEREOF

#6 | 2025-07-17
US20250231185A1
Physics

Coronavirus T Cell Epitopes, Megapools and Uses Thereof

#7 | 2024-12-12
US20240409587A1
Chemistry; metallurgy

Coronavirus T Cell Epitopes and Uses Thereof

#8 | 2024-09-05
US20240294900A1
Chemistry; metallurgy

Common Cold Coronavirus T Cell Epitopes, Methods and Uses Thereof

#9 | 2024-08-08
US20240263237A1
Chemistry; metallurgy

T CELL TRANSCRIPTOMIC PROFILES IN PARKINSON'S DISEASE, AND METHODS AND USES THEREOF

#10 | 2023-09-21
US20230293630A1
Human necessities

Coronavirus T Cell Epitopes and Uses Thereof

#11 | 2022-08-18
US20220259288A1
Chemistry; metallurgy

HUMAN APOB100 EPITOPES, METHODS AND USES FOR MODULATING INFLAMMATORY RESPONSES, AND TREATING ADVERSE CARDIOVASCULAR EVENTS, DISEASE AND ATHEROSCLEROSIS

#12 | 2020-09-17
US20200289629A1
Human necessities

TOXOPLASMA GONDII VACCINES AND THEIR USE

#13 | 2020-04-23
US20200123213A1
Chemistry; metallurgy

IMMUNOGENIC PROTEINS AND FRAGMENTS THEREOF FROM ALLERGENIC MITES

#14 | 2020-03-26
US20200095296A1
Chemistry; metallurgy

USE OF PEPTIDES AS BIOMARKERS IN THE DIAGNOSIS, CONFIRMATION AND TREATMENT OF A NEUROLOGICAL DISORDER AND TCR AND/OR HLA IMMUNOPROFILING IN NEURODEGENERATIVE DISEASE

#15 | 2020-01-30
US20200031905A1
Chemistry; metallurgy

Human APOB100 epitopes, methods and uses for modulating inflammatory responses, and treating adverse cardiovascular events, disease and atherosclerosis

#16 | 2019-09-19
US20190282679A1
Human necessities

TOXOPLASMA GONDII VACCINES AND THEIR USE

#17 | 2019-07-04
US20190202875A1
Chemistry; metallurgy

Immunogenic proteins and fragments thereof from allergenic mites

#18 | 2018-10-11
US20180291071A1
Chemistry; metallurgy

Antigens and T cell epitopes from cockroach and methods of making and using same

#19 | 2018-07-26
US20180207228A1
Human necessities

Peptide combinations and uses thereof for treating grass allergy

#20 | 2018-03-22
US20180078637A1
Human necessities

Epitopes from allergen proteins and methods and uses for immune response modulation

#21 | 2017-06-29
US20170184612A1
Physics

USE OF LEUKOCYTES AND NOVEL BIOMARKERS IN THE DIAGNOSIS, CONFIRMATION, AND TREATMENT OF A NEUROLOGICAL DISORDER

#22 | 2017-02-02
US20170028049A1
Human necessities

Specific and unique T cell responses and molecular signatures for the treatment and diagnosis of

#23 | 2017-02-02
US20170028041A1
Human necessities

HLA-A2 tumor associated antigen peptides and compositions

#24 | 2016-10-06
US20160287696A1
Human necessities

PAN POLLEN IMMUNOGENS AND METHODS AND USES FOR IMMUNE RESPONSE MODULATION

#25 | 2016-09-01
US20160251403A1
Chemistry; metallurgy

Peptide combinations and uses thereof in treating dust mite allergy

#26 | 2016-07-07
US20160193316A1
Human necessities

Inducing Cellular Immune Responses to Plasmodium Falciparum Using Peptide and Nucleic Acid Compositions

#27 | 2016-02-23
US9390061
Chemistry; metallurgy

Inducing cellular immune responses to using peptide and nucleic acid compositions

#28 | 2015-04-23
US20150110819A1
Chemistry; metallurgy

T cell epitopes from Cockroach and methods of making and using same

#29 | 2015-01-22
US20150023992A1
Chemistry; metallurgy

Timothy grass allergens and methods and uses for immune response modulation

#30 | 2015-01-01
US20150004189A1
Human necessities

EPITOPES FROM ALLERGEN PROTEINS AND METHODS AND USES FOR IMMUNE RESPONSE MODULATION

#31 | 2014-06-03
US10116118
-

Heteroclitic analogs and related methods

#32 | 2014-05-29
US20140147490A1
Human necessities

HLA CLASS I A2 TUMOR ASSOCIATED ANTIGEN PEPTIDES AND VACCINE COMPOSITIONS

#33 | 2014-05-22
US20140141064A1
Chemistry; metallurgy

HLA-A2 tumor associated antigen peptides and compositions

#34 | 2014-01-02
US20140004151A1
Chemistry; metallurgy

Antigens and epitopes derived from

#35 | 2013-01-17
US20130017253A1
Chemistry; metallurgy

Inducing Cellular Immune Responses to Human Papillomavirus Using Peptide and Nucleic Acid Compositions

#36 | 2012-07-19
US20120183598A1
Human necessities

HLA-A2 TUMOR ASSOCIATED ANTIGEN PEPTIDES AND COMPOSITIONS

#37 | 2012-06-07
US20120141465A1
Chemistry; metallurgy

Virus vaccination and treatment methods with OX40 agonist compositions

#38 | 2012-01-19
US20120015401A1
Chemistry; metallurgy

PLASMODIUM FALCIPARUM ANTIGENS AND METHODS OF USE

#39 | 2011-12-29
US20110318408A1
Human necessities

HLA CLASS I A2 TUMOR ASSOCIATED ANTIGEN PEPTIDES AND VACCINE COMPOSITIONS

#40 | 2011-06-23
US20110150914A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR DENGUE VIRUS (DV) TREATMENT AND VACCINATION

#41 | 2011-04-28
US20110097352A9
Chemistry; metallurgy

Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions

#42 | 2010-08-19
US20100209493A1
Human necessities

HLA-A2 tumor associated antigen peptides and compositions

#43 | 2010-03-18
US20100068228A1
Chemistry; metallurgy

Inducing Cellular Immune Responses to Hepatitis B Virus Using Peptide and Nucleic Acid Compositions

#44 | 2010-03-18
US20100068218A1
Human necessities

Optimized multi-epitope constructs and uses thereof

#45 | 2010-02-25
US20100049491A1
Human necessities

Method and System for Optimizing Minigenes and Peptides Encoded Thereby

#46 | 2009-12-24
US20090317412A1
Human necessities

Induction of an immune response against streptococcus pneumoniae polyaccharides

#47 | 2009-12-17
US20090311283A1
Chemistry; metallurgy

Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions

#48 | 2009-12-10
US20090304746A1
Chemistry; metallurgy

Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositions

#49 | 2009-08-27
US20090214632A1
Chemistry; metallurgy

Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions

#50 | 2009-07-02
US20090169574A1
Chemistry; metallurgy

Heteroclitic analogs and related methods

#51 | 2009-01-08
US20090012004A1
Human necessities

HLA binding peptides and their uses

#52 | 2008-12-09
US9894018
-

Method and system for optimizing minigenes and peptides encoded thereby

#53 | 2008-11-13
US20080279924A1
Human necessities

HLA class I A2 tumor associated antigen peptides and vaccine compositions

#54 | 2008-11-06
US20080274129A1
Human necessities

Hla-A2 Tumor Associated Antigen Peptides and Compositions

#55 | 2008-10-23
US20080260762A1
Chemistry; metallurgy

HLA binding motifs and peptides and their uses

#56 | 2007-08-09
US20070184519A1
Chemistry; metallurgy

Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production

#57 | 2007-08-07
US9189702
-

HLA binding peptides and their uses

#58 | 2007-05-03
US20070098776A1
Human necessities

HLA class I A2 tumor associated antigen peptides and vaccine compositions

#59 | 2007-04-10
US9709774
-

Alteration of immune response using pan DR-binding peptides

#60 | 2007-03-15
US20070059799A1
Chemistry; metallurgy

Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions

#61 | 2007-03-08
US20070055049A1
Chemistry; metallurgy

HLA binding motifs and peptides and their uses

#62 | 2007-03-08
US20070054262A1
Chemistry; metallurgy

Methods of identifying optimal variants of peptide epitopes

#63 | 2007-03-08
US20070053922A1
Chemistry; metallurgy

Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions

#64 | 2007-03-01
US20070048330A1
Human necessities

Optimized multi-epitope constructs and uses thereof

#65 | 2007-01-25
US20070020327A1
Human necessities

Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions

#66 | 2006-07-27
US20060165719A1
Chemistry; metallurgy

antigens and methods of use

#67 | 2006-05-04
US20060094649A1
Chemistry; metallurgy

Hla-a1,-a2,-a3,-a24,-b7, and-b44 tumor associated antigen peptides and compositions

#68 | 2006-05-04
US20060093617A1
Chemistry; metallurgy

Peptides for inducing a CTL and/or HTL response to hepatitis C virus

#69 | 2006-04-13
US20060079453A1
Chemistry; metallurgy

Hla binding peptides and their uses

#70 | 2006-04-11
US9641528
-

Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions

#71 | 2006-01-26
US20060018915A1
Chemistry; metallurgy

Heteroclitic analogs and related methods

#72 | 2005-12-08
US20050271676A1
Chemistry; metallurgy

Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions

#73 | 2005-09-08
US20050196403A1
Chemistry; metallurgy

Inducing cellular immune responses to p53 using peptide and nucleic acid compositions

#74 | 2005-03-24
US20050063983A1
Chemistry; metallurgy

Inducing cellular immune responses to hepatitis B virus using peptide compositions

#75 | 2005-03-03
US20050049197A1
Chemistry; metallurgy

Induction of immune response against desired determinants

InventorID:

40390 ⎘